Overview

Congrong Runtong Oral Liquid in the Treatment of Functional Constipation (Yang-deficiency Type)

Status:
Not yet recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
Using a placebo as a control, this study aims to preliminarily evaluate the clinical efficacy of Congrong Runtong oral liquid for the treatment of functional constipation (Yang-deficiency type), explore the optimal dosage of Congrong Runtong oral liquid for functional constipation (Yang-deficiency type) to provide a basis for dosage selection in Phase III clinical trials, and observe the safety of clinical use of Congrong Runtong oral liquid.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Hospital of Traditional Chinese Medicine